Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- KALU -23.2%, NURO -9.5%, EBAY -5.9%, UN -4.4%, PM -4.3%, NAP-3.9%, UAL -3.1%, HCCI -3%, AXP -1.7%, AA -1.6%, HXL -1.6%, STLD-1.6%, OIS -1.3%, (revises guidance due to the impacts of Hurricane Harvey - sees Q3 revs of approx $164 mln vs $165-185 mln prior guidance and $176.46 mln CapIQ consensus), VMI -1.2%, SAP -1.1%,TXT -1.1%, CCI -1%, BK -0.9%, KEY -0.7%, YRCW -0.6%, HCA -0.6%, PPG-0.5%
Other news:
- OPTT -30% (intends to offer shares of its common stock )
- ESTE -13.2% (provided Q3 update -- estimates production of 9,671 Boepd; revising 2017 capital expenditures downward to $85 mln from $115 mln; commences underwritten public offering of 4.5 mln shares of its Class A common stock)
- BXC -5.7% (prices secondary offering by Selling Stockholder of 3,863,850 shares of common stock at $7.00 per share)
- PEGI -5.4% (commences 8 mln common stock offering)
- RXDX -4% (files mixed securities shelf offering; commences $125 mln common stock offering)
- THC -1.7% (on HCA guidance)
- KMG -1.5% (prices 3 mln shares of common stock for gross proceeds of $162 mln)
- AGN -1.2% (continued weakness; also issued an FAQ document responding to investor questions following the U.S. District Court for the Eastern District of Texas trial decision on the RESTASIS patents announced earlier this week)
- CUI -1% (prices 6,428,571 shares of common stock at a $2.80 per share), .
Analyst comments:
- MZOR -5% (downgraded to Underweight at Barclays)
- KBH -3.8% (downgraded to Neutral from Outperform at Wedbush)
- SAH -3.6% (downgraded to Underperform from Neutral at BofA/Merrill)
- NKE -1.8% (downgraded to Neutral from Buy at Goldman)
- HAIN -1.4% (downgraded to Market Perform from Outperform at BMO Capital Markets )
- AGN -1.3% (downgraded to Neutral from Buy at Mizuho)
- GWW -0.9% (downgraded to Sell from Neutral at UBS)
- RIO -0.5% (downgraded to Hold from Buy at S&P Global )